Redmile Group, LLC (CIK 1425738) reported 16 SEC Form 4 insider transactions across 5 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy ATTO (782,854 shares), Buy ATTO (200,000 shares), Buy ATTO (400,000 shares), Buy ATRA (195,211 shares), Sell ATRA (60 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 782,854 | $0 |
| 2026-08-07 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 200,000 | $3.4M |
| 2026-08-07 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 400,000 | $6.8M |
| 2026-07-24 | Atara Biotherapeutics, Inc. (ATRA) | Director | Buy | 195,211 | $0 |
| 2026-07-24 | Atara Biotherapeutics, Inc. (ATRA) | Director | Sell | 60 | $0 |
| 2026-04-22 | FATE THERAPEUTICS INC (FATE) | Director | Sell | 9.0M | $0 |
| 2026-04-22 | FATE THERAPEUTICS INC (FATE) | Director | Buy | 9.0M | $0 |
| 2026-04-02 | ADC Therapeutics SA (ADCT) | 10% Owner | Sell | 196,229 | $736,251 |
| 2026-04-02 | ADC Therapeutics SA (ADCT) | 10% Owner | Sell | 188,407 | $706,903 |
| 2026-04-02 | ADC Therapeutics SA (ADCT) | 10% Owner | Sell | 169,265 | $643,038 |
| 2026-04-02 | ADC Therapeutics SA (ADCT) | 10% Owner | Sell | 162,517 | $617,402 |
| 2026-04-02 | ADC Therapeutics SA (ADCT) | 10% Owner | Sell | 2.6M | $8.6M |
| 2026-04-02 | ADC Therapeutics SA (ADCT) | 10% Owner | Sell | 2.5M | $8.3M |
| 2025-08-15 | IGM Biosciences, Inc. (IGMS) | Director | Sell | 3.0M | $0 |
| 2025-07-02 | IGM Biosciences, Inc. (IGMS) | Director | Buy | 828 | $0 |
| 2025-04-02 | IGM Biosciences, Inc. (IGMS) | Director | Buy | 828 | $0 |
Source: SEC Form 4 filings · as of 2026-08-07